Beijing Zhongke Journal Publising Co. Ltd. Liver disease causes more than 2 million deaths annually, accounting for approximately 4% of global mortality. The hepatic vascular system plays a crucial ...

Organoid technologies have become a powerful emerging tool to model liver diseases, for drug screening, and for personalized treatments. Assoc. Prof. Tamer önder of Koç University and his team ...

Results show that percutaneous hepatic perfusion with CHEMOSAT® is an effective and safe treatment option for patients with advanced cholangiocarcinoma and has the potential to prolong life in ...

Pressure enabled drug deliver (PEDD) method significantly increased penetration of glass microspheres into porcine liver tumors (117%; p=0.004 and 39%; p=0.032) with lobar infusions and selective ...

Drugs are metabolized in the liver using several enzyme-catalyzed processes. These enzymes are collectively referred to as the hepatic microsomal enzyme system, and they are usually present in the ...

Researchers are improving the odds for patients with the development of an implantable soft electronic vascular monitoring system. Their smart stent and printed soft sensors, is capable of wireless ...

WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced Food and Drug Administration PMA approval for ...

NEW YORK, Jan. 31, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today ...

June 5, 2007 — The US Food and Drug Administration (FDA) has granted supplemental premarket approval for a continuous glucose monitoring system for the management of diabetes, and granted 510(k) ...